Aug 8, 2018 9:45:00 AM
We have written on the blog in the past about the value that a statistical consultant can bring to your team, and to the overall clinical development process. Statistical consultants can be instrumental to the success of your development program, providing a variety of input from creating innovative trial designs that improve information quality and efficiency, to supporting regulatory...
Topics: Cytel Strategic Consulting, pharmacometrics, quantitative decision-making, model-informed-drug-development
May 31, 2018 3:48:00 PM
By Esha Senchaudhuri
An important trend in clinical development involves integrating strategic pharmacometric analysis with program level decision-making, to make the most use of available data. This can occur in various forms, from leveraging preclinical data for go-no-go decision making [1], to the need for improved comparative effectiveness frameworks [2].
Here we have five reasons why you...
Topics: biostatistics, pharmacometrics, pharmacology, meta-analysis, quantitative decision-making
May 2, 2018 5:07:00 AM
PSI is a global member organization dedicated to leading and promoting best practice and industry initiatives for statisticians in the biopharmaceutical industry. The PSI annual conference is going from strength to strength, attracting increasing numbers of delegates from Europe and beyond. With the 2018 conference taking place in Amsterdam in only a month’s time, we took the opportunity to...
Topics: biostatistics, data science, quantitative decision-making
Apr 3, 2018 2:00:00 PM
Topics: Program and Portfolio Optimization, quantitative decision-making, clinical development
